BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification.

Mol Cancer · 2013 · PMC3695801 · PMID 23758992

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

performed immunolabelling studies on 107 cases of DLBCL (diffuse large B-cell lymphoma) and showed a trend towards poorer survival in patients with BCL11A-xL-negative tumors [ 23 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.